High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.
Details
Download: 1-s2.0-S2666914523000106-main.pdf (450.87 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_ACD5958847C7
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.
Journal
Ophthalmology science
ISSN
2666-9145 (Electronic)
ISSN-L
2666-9145
Publication state
Published
Issued date
09/2023
Peer-reviewed
Oui
Volume
3
Number
3
Pages
100278
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Abstract
To investigate the association between the 2 acute phase proteins, C-reactive protein (CRP) and pentraxin 3 (PTX3) with central serous chorioretinopathy (CSCR), as PTX3 is a glucocorticoid-induced protein.
Cross-sectional multicenter study.
Patients with CSCR compared with age- and sex-matched healthy participants.
Patients with CSCR from 3 centers in Europe were included in the study. The clinical form of CSCR was recorded. Blood samples from patients with CSCR and healthy participants were sampled, and high-sensitivity CRP and PTX3 levels were measured in the serum.
C-reactive protein and PTX3 serum level comparison between patients with CSCR with age- and sex-matched healthy participants.
Although CRP levels were higher in patients with CSCR (n = 216) than in age- and sex-matched controls (n = 130) (2.2 ± 3.2 mg/l vs. 1.5 mg/l ± 1.4, respectively, P = 0.037), PTX3 levels were lower in patients with CSCR (10.5 ± 19.9 pg/ml vs. 87.4 ± 73.2 pg/ml, respectively, P < 0.001). There was no significant difference in CRP or PTX3 levels between patients with acute/recurrent and chronic CSCR.
In patients with CSCR, high CRP and low PTX3 levels suggest a form of low-grade systemic inflammation together with a lack of glucocorticoid pathway activation, raising new hypotheses on the pathophysiology of CSCR.
The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Cross-sectional multicenter study.
Patients with CSCR compared with age- and sex-matched healthy participants.
Patients with CSCR from 3 centers in Europe were included in the study. The clinical form of CSCR was recorded. Blood samples from patients with CSCR and healthy participants were sampled, and high-sensitivity CRP and PTX3 levels were measured in the serum.
C-reactive protein and PTX3 serum level comparison between patients with CSCR with age- and sex-matched healthy participants.
Although CRP levels were higher in patients with CSCR (n = 216) than in age- and sex-matched controls (n = 130) (2.2 ± 3.2 mg/l vs. 1.5 mg/l ± 1.4, respectively, P = 0.037), PTX3 levels were lower in patients with CSCR (10.5 ± 19.9 pg/ml vs. 87.4 ± 73.2 pg/ml, respectively, P < 0.001). There was no significant difference in CRP or PTX3 levels between patients with acute/recurrent and chronic CSCR.
In patients with CSCR, high CRP and low PTX3 levels suggest a form of low-grade systemic inflammation together with a lack of glucocorticoid pathway activation, raising new hypotheses on the pathophysiology of CSCR.
The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Keywords
General Earth and Planetary Sciences, General Environmental Science, AMD, age-related macular degeneration, C-reactive protein, CRP, C-reactive protein, CSCR, central serous chorioretinopathy, Central serous chorioretinopathy, FH, factor H, Glucocorticoid, HPA, hypothalamic-pituitary-adrenal, IL, interleukin, Inflammation, Pentraxin 3, PTX, pentraxin
Pubmed
Web of science
Open Access
Yes
Create date
05/04/2023 14:37
Last modification date
05/10/2023 6:14